Burden of Clostridium difficile infection in the United States.
暂无分享,去创建一个
J. Meek | D. Gerding | S. Fridkin | B. Limbago | W. Bamberg | Z. Beldavs | G. Dumyati | L. Wilson | F. Lessa | L. McDonald | J. Dunn | M. Farley | Yi Mu | S. Holzbauer | E. Phipps | L. Winston | Jessica a. Cohen | Erin C. Phipps | Wendy M. Bamberg
[1] J. Bartlett,et al. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. , 1981, Gastroenterology.
[2] R. Möllby,et al. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. , 1985, The Journal of infectious diseases.
[3] Roderick J. A. Little,et al. Multiple Imputation for the Fatal Accident Reporting System , 1991 .
[4] R. Platt,et al. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. , 1994, The Journal of infectious diseases.
[5] Sharon L. Lohr,et al. Sampling: Design and Analysis , 1999 .
[6] Christiane,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.
[7] T. Åkerlund,et al. Molecular Epidemiology of Hospital-Associated and Community-Acquired Clostridium difficile Infection in a Swedish County , 2004, Journal of Clinical Microbiology.
[8] D. Musher,et al. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. , 2005, The Lancet. Infectious diseases.
[9] Ken Dewar,et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.
[10] Stuart Johnson,et al. An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.
[11] A. Robicsek,et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] C. Woods,et al. Comparison of Seven Techniques for Typing International Epidemic Strains of Clostridium difficile: Restriction Endonuclease Analysis, Pulsed-Field Gel Electrophoresis, PCR-Ribotyping, Multilocus Sequence Typing, Multilocus Variable-Number Tandem-Repeat Analysis, Amplified Fragment Length Polymorphis , 2007, Journal of Clinical Microbiology.
[13] S. Persson,et al. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[14] M. Wilcox,et al. A case-control study of community-associated Clostridium difficile infection. , 2008, The Journal of antimicrobial chemotherapy.
[15] R. Campbell,et al. Clostridium difficile Infection in Ohio Hospitals and Nursing Homes During 2006 , 2009, Infection Control & Hospital Epidemiology.
[16] Mark A. Miller,et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] M. P. Bauer,et al. The Changing Epidemiology of Clostridium difficile Infections , 2010, Clinical Microbiology Reviews.
[18] C. Burnham,et al. Impact of Clinical Symptoms on Interpretation of Diagnostic Assays for Clostridium difficile Infections , 2011, Journal of Clinical Microbiology.
[19] D. Anderson,et al. Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals , 2011, Infection Control & Hospital Epidemiology.
[20] C. Donskey,et al. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] Anil K. Jain,et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] D. Nathwani,et al. Control of an outbreak of diarrhoea in a vascular surgery unit caused by a high-level clindamycin-resistant Clostridium difficile PCR ribotype 106. , 2011, The Journal of hospital infection.
[23] N. Khardori. Clostridium difficile infection in Europe: a hospital-based survey , 2011 .
[24] J. Weese,et al. Clostridium difficile and methicillin-resistant Staphylococcus aureus shedding by slaughter-age pigs , 2011, BMC veterinary research.
[25] J. Stockman. Treatment with Monoclonal Antibodies against Clostridium difficile Toxins , 2011 .
[26] Guang-xi Li,et al. Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the Society for Healthcare Epidemiology of America(SHEA)and the Infectious Diseases Society of America(IDSA) , 2011 .
[27] C. Mcnulty,et al. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. , 2012, The Journal of antimicrobial chemotherapy.
[28] Margaret A. Olsen,et al. Burden of Clostridium difficile on the Healthcare System , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] Amanda F. Petrik,et al. Clostridium difficile Infection, Colorado and the Northwestern United States, 2007 , 2012, Emerging infectious diseases.
[30] M. Cairns,et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] M. Nauta,et al. Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009 , 2012, Epidemiology and Infection.
[32] J. Weese,et al. Prevalence and molecular characterization of Clostridium difficile isolated from feedlot beef cattle upon arrival and mid-feeding period , 2012, BMC Veterinary Research.
[33] J. Haagsma,et al. Disease burden of foodborne pathogens in the Netherlands, 2009. , 2012, International journal of food microbiology.
[34] G. Dumyati,et al. Burden of Clostridium difficile Infection in Long-Term Care Facilities in Monroe County, New York , 2012, Infection Control & Hospital Epidemiology.
[35] A. Curns,et al. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] T. Peto,et al. Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] A. Carmichael,et al. Mortality in Clostridium difficile infection: a prospective analysis of risk predictors , 2013, European journal of gastroenterology & hepatology.
[38] K.,et al. Attributable Burden of Hospital-Onset Clostridium difficile Infection: A Propensity Score Matching Study , 2013, Infection Control & Hospital Epidemiology.
[39] D. Crook,et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection , 2013, Lancet. Infectious Diseases (Print).
[40] O. Dekkers,et al. All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] S. Trottier,et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] D. Gerding,et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] D. Gerding,et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. , 2013, JAMA internal medicine.
[44] B. Limbago,et al. Impact of Changes in Clostridium difficile Testing Practices on Stool Rejection Policies and C. difficile Positivity Rates across Multiple Laboratories in the United States , 2013, Journal of Clinical Microbiology.
[45] D. Harris,et al. Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[46] S. Cosgrove,et al. Gut Check: Clostridium difficile Testing and Treatment in the Molecular Testing Era , 2014, Infection Control & Hospital Epidemiology.
[47] M. Olsen,et al. Development and validation of a recurrent Clostridium difficile risk-prediction model. , 2014, Journal of hospital medicine.
[48] K. Garey,et al. Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile–Associated Disease Rates1 , 2014, Infection Control & Hospital Epidemiology.
[49] J. Meek,et al. Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations , 2014, Open forum infectious diseases.
[50] J. Meek,et al. Clostridium difficile Infection Among Children Across Diverse US Geographic Locations , 2014, Pediatrics.
[51] D. Gerding,et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] R. Lynfield,et al. Multistate point-prevalence survey of health care-associated infections. , 2014, The New England journal of medicine.
[53] Monique L. Anderson,et al. Compliance with results reporting at ClinicalTrials.gov. , 2015, The New England journal of medicine.
[54] J. Bartlett. Clostridium difficile Infection. , 2017, Infectious disease clinics of North America.